Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model

KOHEI MIZUTA(University of the Ryukyus), R. M. Hoffman(University of California San Diego)

In Vivo

February 27, 2026

10.21873/invivo.14239

Cited by 0

Related Papers

Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts

|Anticancer Research|2025|2

Eradication of Extensive Lymph‐Node, Bone and Pleural Metastases of a Breast‐Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase

|Cancer Diagnosis & Prognosis|2025|1

Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression

|Frontiers in Oncology|2025|1